View on market: Stay Cautious, be with quality business:
Asia stocks fell at the open Wednesday after U.S. stocks saw their worst day since May and bond yields spiked on concerns about inflation. Treasuries added to a decline. Equities fell in Japan, Australia and South Korea as mounting concerns over the debt-ceiling impasse in Washington added to investor angst. U.S. futures rose after the S&P 500 closed 2% lower — the most since May. Technology shares fared worse than economically sensitive stocks as Treasury yields climbed. The Nasdaq 100 tumbled the most since March. The Singapore-traded SGX Nifty, an early indicator of India’s Nifty 50 Index’s performance, fell 0.53% to 17,630.50 as of 7:55 a.m. The 10-year Treasury yield edged higher. Earlier, the yield on the 30-year note jumped almost 10 basis points.
Economic Calendar:
- INR: Foreign Debt (USD) (Q2) on 30th September, 2021
- INR: Infrastructure Output (YoY) (Aug) on 30th September, 2021.
- USD: Pending Home Sales (MoM) (Aug) on 29th September, 2021.
- USD: Crude Oil Inventories on 29th September,2021.
Brokerage Radar:
CLSA ON BEL: Maintain buy at the price of Rs 210.3 for the target price of Rs 250. Adds SAAS to new business opportunities of ammunition & EV batteries. Intent is to derive 25% of its topline from civilian market. Co confident of catching up over the rest of FY22. Raise FY23-24 EPS estimates 2-6%. Co guided it would sustain mid- teen growth for 3-4 years.
CLSA ON OIL& GAS: Marketing margin on gasoline/diesel remain above long-term averages. ONGC remains top sector buy, pricing in only about $45/bbl of Brent. See domestic gas price potentially rising 300% in a year.
International Markets:
U.S & Europe
| Particulars | 28th Sept | Chg | Chg(%) |
| Nasdaq | 14,546.68 | -423.29 | -2.83 |
| Dow | 34,299.99 | 569.38 | -1.63 |
| FTSE | 7,028.10 | -35.30 | -0.50 |
| CAC | 6,506.50 | -144.41 | -2.17 |
| DAX | 15,248.56 | -325.32 | -2.09 |
| Dow Fut.* | 34,296.00 | 121.00 | 0.35 |
Asian markets:
| Particulars | 29th Sept | Chg | Chg(%) |
| SGX Nifty | 17,630.50 | -94.00 | -0.53 |
| Nikkei | 29,376.25 | -807.71 | -2.68 |
| Straits Times | 3,069.44 | -8.25 | -0.27 |
| Hang Seng | 24,255.05 | -245.34 | -1.00 |
| Shanghai | 3,552.79 | -49.43 | -1.37 |
ADR Watch:
| Particulars | 28th Sept | Chg | Chg(%) |
| Dr Reddy | 64.61 | -0.05 | -0.08 |
| HDFC Bank | 72.01 | -2.43 | -3.26 |
| ICICI Bank | 18.98 | -0.87 | -4.38 |
| Infosys | 22.09 | -0.81 | -3.54 |
| Tata Motor | 22.07 | -0.74 | -3.24 |
| Wipro | 8.83 | -0.32 | -3.50 |
Commodities & Currency
| Particulars | Current Price | Chg(%) |
| USD/INR | 74.31 | 0.36 |
| Brent | 77.47 | -1.12 |
| Gold | 1738.25 | 0.04 |
| Silver | 22.534 | 0.34 |
FIIs & DII
| Particulars | 28th Sept | 27th Sept |
| FIIs | -1957.40 | -594.63 |
| DIIs | 161.45 | 1397.69 |
News Update:
HDFC Asset Management Company: Promoter Standard Life Investment seeks up to $411 million from HDFC AMC share sale, according to terms of the deal. The promoter is offering 1.06 crore shares in HDFC AMC in an accelerated placement. The floor price has been fixed at Rs 2,870, which is at a discount of 6.68% to Tuesday’s closing price.
Mahindra & Mahindra: The company is weighing options to raise funds for its Automobili Pininfarina unit as it seeks to bring a delayed $2.2 million electric hypercar into production, according to a Bloomberg report.
Lupin: The company has launched Droxidopa Capsules in the United States. Droxidopa Capsules is a generic equivalent of Northera Capsules of Lundbeck NA Ltd., indicated for the treatment of orthostatic dizziness and light-headedness in adult patients.
Bharti Airtel: CRISIL Ratings has upgraded its long-term rating on the bank facilities and debt programme of Bharti Airtel to AA+/Stable from AA/Stable and has reaffirmed the A1+ rating on the commercial paper programme.
Max Healthcare Institute: Kayak Investments, one of the promoters of the company, will offload about 6.3 crore shares of Max Healthcare for at least 2,220 crore. Shares could be sold at a price between Rs 350-370 per share.
Future Group stocks: The NCLT, Mumbai bench has passed an order allowing the group to hold meetings of shareholders and creditors to seek approval for the scheme of arrangement. The scheme has been proposed between 20 Future Group entities, including 6 listed companies, with Reliance Retail Ventures and Reliance Retail and Fashion Lifestyle. The NCLT has also rejected the intervention application.
Aditya Birla Sun Life AMC:The company’s initial public offer opens for bidding today and closes on October 1. The company plans to raise Rs 2,768.25 crore through its public issue and the price band was fixed at Rs 695-712 per share.
NBCC India: The total estimated cost of construction for a project has increased to Rs 1,942 crore, out of which Rs 1,000 was sanctioned to NBCC in FY 2020-21. Accordingly, in continuation, the company will get an additional business amounting to Rs 942 crore.
Infosys: The company and SAP collaborated to drive business innovation with new leads and proposals solution for the professional services industry.
Atul Auto: The commercial production at Bhayla, Ahmedabad plant of the company for manufacturing three-wheeler automobiles commenced on September 27.
AGMs: Vodafone Idea (3 p.m.); Indian Railway Catering (12:30 p.m.); Mphasis (9 a.m.); Container Corp. (3 p.m.); Engineers India (3 p.m.); Birla Corp (10:30 a.m.); Emami (11:30 a.m.); Dalmia Bharat (11:30 a.m.); Max Healthcare Institute (12 noon); RailTel Corp, NHPC, Cochin Shipyard, MOIL, Future Consumer, Zee Media Corp., Zee Learn, Ujjivan Financial, Religare Enterprises,
Source: Moneycontrol, Livemint,, Bloomberg, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL